Treatment of liver steatosis and fibrosis with resmetirom- NEJM Feb 8, 2024
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
N Engl J Med 2024; 390:497-509
DOI: 10.1056/NEJMoa2309000 February 8, 2024
Leave a reply →
Post più commentati